Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study

Lin Fu, Jun Fei, Hui-Xian Xiang, Ying Xiang, Zhu-Xia Tan, Meng-Die Li, Fang-Fang Liu, Hong-Yan Liu, Ling Zheng, Ying Li, Hui Zhao, De-Xiang Xu
doi: https://doi.org/10.1101/2020.03.13.20035329
Lin Fu
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
2Department of Toxicology, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Fei
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui-Xian Xiang
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Xiang
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhu-Xia Tan
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meng-Die Li
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang-Fang Liu
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong-Yan Liu
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling Zheng
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Li
3Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430040, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhao
1Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xudex@126.com zhaohuichenxi@126.com
De-Xiang Xu
2Department of Toxicology, Anhui Medical University, Hefei, Anhui Province, 230032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xudex@126.com zhaohuichenxi@126.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Coronavirus disease 2019 (COVID-19) triggered by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been widely pandemic all over the world. The aim of this study was to analyze the influence factors of death risk among 200 COVID-19 patients.

Methods Two hundred patients with confirmed SARS-CoV-2 infection were recruited. Demographic data and clinical characteristics were collected from electronic medical records. Biochemical indexes on admission were measured and patient’s prognosis was tracked. The association of demographic data, clinical characteristics and biochemical indexes with death risk was analyzed.

Results Of 200 COVID-19 patients, 163 (81.5%) had at least one of comorbidities, including diabetes, hypertension, hepatic disease, cardiac disease, chronic pulmonary disease and others. Among all patients, critical cases, defined as oxygenation index lower than 200, accounted for 26.2%. Severe cases, oxygenation index from 200 to 300, were 29.7%. Besides, common cases, oxygenation index higher than 300, accounted for 44.1%. At the end of follow-up, 34 (17%) were died on mean 10.9 day after hospitalization. Stratified analysis revealed that older ages, lower oxygenation index and comorbidities elevated death risk of COVID-19 patients. On admission, 85.5% COVID-19 patients were with at least one of extrapulmonary organ injuries. Univariable logistic regression showed that ALT and TBIL, two indexes of hepatic injury, AST, myoglobin and LDH, AST/ALT ratio, several markers of myocardial injury, creatinine, urea nitrogen and uric acid, three indexes of renal injury, were positively associated with death risk of COVID-19 patients. Multivariable logistic regression revealed that AST/ALT ratio, urea nitrogen, TBIL and LDH on admission were positively correlated with death risk of COVID-19 patients.

Conclusion Older age, lower oxygenation index and comorbidities on admission elevate death risk of COVID-19 patients. AST/ALT ratio, urea nitrogen, TBIL and LDH on admission may be potential prognostic indicators. Early hospitalization is of great significance to prevent multiple organ damage and improve the survival of COVID-19 patients.

Summary In this hospital-based case-cohort study, we found that serum urea nitrogen, TBIL, LDH and AST/ALT ratio, several markers of extrapulmonary organ injuries, were positively correlated with death risk of COVID-19 patients. We provide evidence for the first time that multiple organ damage on admission influences the prognosis of COVID-19 patients. Early hospitalization is beneficial for elevating the survival rate of COVID-19 patients especially critical ill patients.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Coronavirus disease 2019 (COVID-19) triggered by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been widely pandemic all over the world. After the first patient was reported in December 2019 in Wuhan City, Hubei Province, China, this infecting disease broke out quickly, spread around all over the world and was persistently evolving so far. Until 6 March, 2020, 80581 cases were confirmed to have been infected with SARS-CoV-2 and 3016 cases died from SARS-CoV-2 infection in China. In other countries, total 17024 COVID-19 patients were confirmed and 343 patients died after being infected with SARS-CoV-2. This novel disease is a neo-type respiratory contagious disease that has high infectivity and mortality as well as heavy damage on public health. Clinical trial has been registered before this research. However, it needs a long time to finish all the process, the clinical trial ID is not obtained temporarily and still transacted.

Funding Statement

This study was supported by National Natural Science Foundation of China (81630084) and National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Anhui Medical University (2019GQFY06).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We declare that all data referred to in the manuscript is availability.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 16, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study
Lin Fu, Jun Fei, Hui-Xian Xiang, Ying Xiang, Zhu-Xia Tan, Meng-Die Li, Fang-Fang Liu, Hong-Yan Liu, Ling Zheng, Ying Li, Hui Zhao, De-Xiang Xu
medRxiv 2020.03.13.20035329; doi: https://doi.org/10.1101/2020.03.13.20035329
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study
Lin Fu, Jun Fei, Hui-Xian Xiang, Ying Xiang, Zhu-Xia Tan, Meng-Die Li, Fang-Fang Liu, Hong-Yan Liu, Ling Zheng, Ying Li, Hui Zhao, De-Xiang Xu
medRxiv 2020.03.13.20035329; doi: https://doi.org/10.1101/2020.03.13.20035329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8566)
  • Forensic Medicine (4)
  • Gastroenterology (385)
  • Genetic and Genomic Medicine (1755)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1245)
  • Health Policy (622)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (376)
  • Infectious Diseases (except HIV/AIDS) (10306)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1679)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (254)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1772)
  • Public and Global Health (3845)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (521)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)